What are MCTs?
Medium-chain triglycerides (MCTs) are fats composed of medium-chain fatty acids (C6-C12). MCTs are found in coconut oil, palm kernel oil, and some dietary supplements.
Historical and current recommendations
Historically, there has been concern that MCTs may be dangerous for individuals with MCADD because they are metabolized through the same pathway that is deficient (medium-chain fatty acid β-oxidation).
Orphanet recommendation on MCT
Orphanet (ORPHA:42), an authoritative Tier A source, explicitly states: "Les triglycérides à chaîne moyenne doivent aussi être évités" (medium-chain triglycerides should also be avoided). This recommendation comes from the Orphanet clinical summary for MCADD (last updated February 2014).
Other dietary considerations from Orphanet:
- Artificial sweeteners should be avoided.
- Low-dose carnitine in patients with low carnitine levels is controversial (no consensus).
- Symptomatic patients: simple carbohydrates administered orally (glucose tablets) or intravenously until glycemia is maintained above 5 mmol/L.
- No other dietary restriction is required beyond MCT avoidance and fasting prevention.
!Context and limitationsThe Orphanet recommendation dates from February 2014 and may reflect practices that have since evolved. It does not distinguish between MCT oil supplements and trace MCT in foods. Families should discuss MCT avoidance specifics with their metabolic team.